Donnelly Centre for Cellular and Biomolecular Research

Study Reveals Large Molecular Differences Between Stem Cells Grown on Different Biomaterials

Apr 15, 2019
Author: 
Jovana Drinjakovic

Research associate Jelena Tomic (pictured) and colleagues in Professor Jason Moffat's lab found that stem cells can exhibit vastly different molecular properties depending on the type of surface they adhere to, with implications for research and therapy (Photo by Medicine by Design).

 

The genes neccessary for the growth and survival of stem cells are influenced by the biomaterials on which they're cultured, Donnelly Centre investigators have found.

Different substrates, used to coat the surface of the lab dish for the cells to adhere to, can change the cells’ molecular states—and potentially their behavior—and should be considered in future research.

“Cells are often maintained on different substrates under assumption that the nature of the substrate does not make that much of a difference,” says Jelena Tomic, one of the lead authors on the paper and a research associate in the lab of Jason Moffat, a professor of molecular genetics at the Donnelly Centre.

While there had been reports that these biomaterials can influence certain molecular changes in cells, the extent of those changes had not been studied in detail – until now.

Writing in the journal Cell Reports, researchers led by Jason Moffat, a professor of molecular genetics in the Donnelly Centre, used the gene editing CRISPR technology to study which genes are essential for embryonic stem cell proliferation. They found that two commonly used substrates have a much more profound effect on the cells’ molecular properties than previously appreciated.

The effect is thought to be caused by substrate molecules interacting with receptors on the cell surface to influence cellular behaviour.

In addition to Tomic, post-doctoral researcher Barbara Mair and graduate student Sanna Masud were also lead co-authors of the study. The study itself was done in collaboration with Senior Scientist Gordon Keller’s group at University Health Network, and was made possible thanks to the University of Toronto’s Medicine by Design initiative that supports regenerative medicine research through collaboration among experts from diverse disciplines.

Stem cells, like those found in embryo, hold promise for regenerative medicine thanks to their unique properties. They can multiply to make more stem cells, and they are pluripotent, which means that under right conditions they can turn into any cell type in the body. This makes them an ideal source of cells for generating tissue in the lab to study and treat disease. Over the last couple of decades, researchers have developed a variety of methods to maintain stem cells in a pluripotent state or make them turn into specialized cell types such as neurons.

“Every lab uses a different way of growing cells, it’s what fits your lab best,” says Masud. “But, our data show that it clearly makes quite a significant difference what you are growing your cells on.”

To investigate substrate effects, the team split the same batch of stem cells and multiplied them in dishes whose surface was coated with different substrates. One substrate consisted of a bed of immature mouse cells, known as mouse embryonic fibroblasts, or MEFs, which are thought to mimic the cells’ natural environment in the embryo. The other was laminin, a component of the matrix the cells are embedded inside the body. In addition to MEFs and laminin, several other substrates are used for growing stem cells, but their effects remain unclear.

"Our study provides the stem cell field with data to assess how their substrate can inherently bias their cells’ genetic makeup even before they start doing any experiments” - Barbara Mair, Postdoctoral Fellow

The researchers were surprised to find the extent to which the stem cells were dissimilar at the molecular level depending on whether they were grown on MEFs or laminin. First, the scientists looked at differences in gene usage and found that as many as half of all genes that were turned on differed between the two cell populations.

Working with the Centre for Regeneration and Commercialization of Regenerative Medicine in Toronto, the researchers created embryonic stem cells that have an inducible CRISPR switch, allowing them to turn off, one at a time, all of ~20,000 human genes to find those required for pluripotent cell growth. These types of studies were technically too challenging before CRISPR was developed a few years ago. The data revealed that cell proliferation in the pluripotent state in the two cell populations was maintained by partially overlapping sets of genes.

“People have anecdotally observed that the growth substrate can affect the cells’ behaviour, so that in itself is not too surprising but the large extent to which it does is very surprising,” says Mair. “Our study provides the stem cell field with data to assess how their substrate can inherently bias their cells’ genetic makeup even before they start doing any experiments.”

The study also uncovered several novel genes essential for stem cell growth on both MEFs and laminin and which will be the focus of future research.

The work was also supported by research grants from the Canadian Institutes of Health Research, while Moffat holds Canada Research Chair in Functional Genomics of Cancer.

Follow us on Twitter to keep up with Donnelly Centre news.